NEUBASE THERAPEUTICS INC (NBSE) Stock Balance Sheet
USA - NASDAQ:NBSE - US64132K2015 - Common Stock
0.378 USD
-0.01 (-3.2%)
0.42 USD
+0.04 (+11.11%)
| MRQ (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | 2019 (2019-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 12.57M | 23.15M | 52.89M | 31.99M | 10.31M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 0 | 150.00K | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 780.00K | 1.50M | 2.04M | 820.00K | 720.00K | |||
| Total Current Assets | 13.35M | 24.65M | 54.93M | 32.81M | 11.03M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.14M | 7.77M | 8.41M | 1.17M | 430.00K | |||
| Investments And Advances | null | 0 | 420.00K | 320.00K | 590.00K | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | 0 | 150.00K | |||
| Other Non-Current Assets | 130.00K | 270.00K | 410.00K | 150.00K | 340.00K | |||
| Total Non-Current Assets | 5.27M | 8.04M | 9.24M | 1.63M | 1.50M | |||
| TOTAL ASSETS | 18.62M | 32.69M | 64.17M | 34.44M | 12.53M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 150.00K | 140.00K | 120.00K | |||
| Current Portion Of LT Debt. | 0 | 110.00K | 110.00K | null | null | |||
| Accrued Expenses | 960.00K | 2.22M | 2.13M | 560.00K | 410.00K | |||
| Accounts Payable | 260.00K | 1.84M | 1.81M | 1.51M | 1.48M | |||
| Other Current Liabilities | 3.43M | null | 0 | 950.00K | 500.00K | |||
| Total Current Liabilities | 4.65M | 4.17M | 4.19M | 3.15M | 2.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 110.00K | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 4.83M | 5.34M | 5.79M | null | null | |||
| Total Non-Current Liabilities | 4.83M | 5.33M | 5.91M | 0 | 0 | |||
| TOTAL LIABILITIES | 9.48M | 9.50M | 10.10M | 3.15M | 2.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -116.47M | -102.74M | -68.97M | -43.56M | -27.00M | |||
| Additional Paid In Capital | 125.61M | 125.93M | 123.03M | 74.85M | 37.03M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 0 | 0 | 0 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 3.73M | 1.65M | 1.64M | 1.16M | 850.00K | |||
| Tangible Book Value per Share | 2.4504 | 14.0545 | 32.9695 | 26.9741 | 11.6235 | |||
| Total Shareholders' Equity | 9.14M | 23.19M | 54.07M | 31.29M | 10.03M | |||
| TOTAL LIABILITIES AND EQUITY | 18.62M | 32.69M | 64.17M | 34.44M | 12.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | N/A | N/A | |||
| Current Ratio | 2.87 | 5.91 | 13.11 | 10.42 | 4.41 | |||
| Return On Assets (ROA) | -73.74% | -103.33% | -39.60% | -50.46% | -208.54% | |||
| Return On Equity (ROE) | -150.22% | -145.67% | -46.99% | -55.54% | -260.52% | |||
All data in USD , ROIC based on taxRate of 0.21